MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Spatial distribution of functional clusters coding for reward and movement information in the striatal direct and indirect pathways

    MW. Jung, JH. Shin (Daejeon, Republic of Korea)

  • Spatial distribution of Parkinson’s disease in the Canton of Geneva, Switzerland

    V. Fleury, R. Himsl, S. Joost, N. Nicastro, I. Guessous, P. Burkhard (Lausanne, Switzerland)

  • Special features of parkinsonism with congenital anomalies of cerebral vessels

    AS. Norboboev, FAY. Odinaev, GUL. Rakhmatullaeva (Tashkent, Uzbekistan)

  • Specific chemosensory pattern in Parkinson’s disease

    C. Tremblay, R. Emrich, A. Cavazzana, L. Klingelhoefer, M. Brandt, T. Hummel, A. Haehner, J. Frasnelli (Trois-Rivières, QC, Canada)

  • Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

    M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

  • Spectrum of motor complications in advanced Parkinson’s disease: data from a large Romanian case series evaluated for suitability for device aided therapy

    J. Szász, V. Constantin, K. Orbán, L. Bancu, D. Georgescu, J. Szederjesi, A. Rácz, I. Mihály, S. Szatmári (Tirgu Mures, Romania)

  • Spectrum of Movement disorders in pediatric immune-mediated diseases

    A. Saan, K. Linn, A. Minaye, C. Hlaing, K. Ko, H. Wintaung, N. Lin, Y. Wintaung (Yangon, Myanmar)

  • Spectrum of parkinsonian phenotypes associated with GCH1 mutation.

    D. Al-Shorafat, A. Shetty, D. Munoz, A. Fasano, A. Lang (Toronto, ON, Canada)

  • Speculation on the timing of iron deposition in the putamen of patients with multiple system atrophy: multimodal MRI study

    MJ. Lee, JH. Lee (Yangsan-Si, Republic of Korea)

  • Speech and language changes in cognitive impairment subtypes in patients with Parkinson´s disease

    A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

  • « Previous Page
  • 1
  • …
  • 177
  • 178
  • 179
  • 180
  • 181
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley